Technology | April 30, 2009

FDA Clears UroCARE Software for NeuViz CT Systems

April 30, 2009 - The FDA has granted 510(k) clearance of UroCARE, a software application package for the assessment of urinary anatomy using multislice computed tomography (CT) data, developed by Neuisys.

Neuisys, a provider of CT and MR imaging systems to physician practices, made the announcement at the annual meeting of the American Urological Association. UroCARE is a software package developed by Neusoft Medical Systems for the NeuViz Dual and NeuViz 16 CT systems. UroCARE is also compatible with DICOM compliant CT image sets, including those from other CT manufacturers.

"The team at Neusoft is very proud to be at the forefront of clinical applications development for high-tech medical imaging," said Yan Kang, M.D., vice president and general manager of Medical IT at Neusoft. "The FDA clearance of UroCARE is an exciting milestone in Neusoft's development of computer assisted reading and evaluation (CARE) packages, and we must share the credit with our clinical partners who have helped our software engineers understand their specific needs from an anatomic and disease process point of view."

UroCARE uses proprietary image processing algorithms to analyze multi-phase CT images of the urinary tract. Its advanced clinical functionality provides a KUB (kidney, ureter, and bladder) view; automatic segmentation of kidneys, ureters, and bladder; and detection of urinary calculi with density and volume measurements. KUB radiography has long been a key part of the daily routine for urology practices. UroCARE's KUB-view can eliminate the need for a dedicated radiography room or the need for patient to go to another facility for a KUB.

"UroCARE was specifically designed for the urologic surgeon to facilitate decision making for ureteroscopy or lithotripsy," said Edward Janosko, M.D., of Atlantic Urology in Wilmington, N.C., and former Chief of Urology at Pitt Memorial Hospital/East Carolina University School of Medicine. "UroCARE enables the display of the entire collecting system as a 3D pyelogram, which urologists are accustomed to reviewing for the detection of filling defects and to separate phleboliths from stones. UroCARE can also assist with the selection of an optimal percutaneous tract for nephrostolithomy. All of these capabilities are completed with a few clicks of the mouse. I know of no other system that can do this."

For m ore information: www.neuisys.com

Related Content

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC).

National Clinical Decision Support Company (NDSC) has an exclusive deal with the American College of Radiology (ACR) to provide medical imaging appropriate use criteria (AUC). 

Feature | Clinical Decision Support | January 18, 2018
January 18, 2018 — Change Healthcare announced the acquisition of National Decision Support Company (NDSC), a leader
Videos | Artificial Intelligence | January 18, 2018
ITN Contributing Editor Greg Freiherr offers an overview of artificial intelligence advances at the Radiological Soci
Philips Introduces Technology Maximizer Program for Imaging Equipment Upgrades
Technology | Imaging | January 17, 2018
January 17, 2018 — Philips recently announced the launch of Technology Maximizer, a cross-modality program designed t
Sponsored Content | Videos | Enterprise Imaging | January 17, 2018
Mitchell Goldburgh, global solutions manager for enterprise imaging and analytics manager for NTT Data Services, form
Sponsored Content | Videos | Enterprise Imaging | January 16, 2018
Built on an over 25-year pioneering legacy in the advanced visualization industry, Vital continues to expand on three
RSNA 2017 Celebrates Innovation in Radiology
News | Imaging | January 15, 2018
January 15, 2018 — The Radiological Society of North America’s...
News | Clinical Decision Support | January 12, 2018
January 12, 2018 — GE Healthcare has entered into a strategic, long-term partnership with Roche to jointly develop an
The artificial intelligence (AI) smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices.

The AI smart algorithm onboard the Infervision stroke product calculates the volume of bleed on the basis of multiple brain CT slices. The size of the bleed volume indicates the urgency and type of treatment required.

Feature | Artificial Intelligence | January 10, 2018 | Greg Freiherr
Exhibitors at the 2017 Radiological Society of North American (RSNA) meeting rode the...
Videos | Enterprise Imaging | January 09, 2018
Konica Minolta President of Healthcare IT Steve Deaton details new features in the Exa Platform designed to improve c
Toshiba Medical Systems Changes Name to Canon Medical Systems Corp.
News | Business | January 08, 2018
Canon Inc. and Canon Medical Systems Corp. announced the official corporate name (trade name) change of Canon Group...
Overlay Init